INTRODUCTION
Continuous glucose monitoring (CGM) devices can estimate blood glucose levels with a 1-5min sampling period. However, the relation between tissue and blood glucose is dynamic and the sensor signal can degrade over time. In addition, CGM readings contains high frequency noise. However, CGM has the potential to improve performance of glycaemia control and reduce nurse workload. A simple model was designed and tested to see the effect of inherent CGM error on the insulin therapy protocol, STAR (Stochastic TARgeted).
Modelling Continuous Glucose Monitoring Output

CGM Patients
Data from 9 patients admitted to the Christchurch Hospital ICU that were enrolled in an observational pilot study of CGM was used to generate the CGM error model
Error Model
Using CGM to guide insulin Therapy -Insilco
Virtual Patients
Virtual trials were performed using retrospective data from 183 patients treated by accurate glycaemic control protocols at Christchurch Hospital ICU between 2011 and 2013.
Results
-reduced workload by~50%.
-low level of hypoglycaemia -under the clinically acceptable value of 5% below <4.0mmol/L -Shows great promised for the future of CGM and their use in clinic, newer generation of sensors being specifically designed for the ICU environment promising less error and drift
CONCLUSION
The STAR CGM protocol gave good performance and reduced workload by ~50%, reducing the number of measurements per day per patient from 13 to 7. The number of hypoglycaemic events increased compared to the current STAR from 0.03% <2.2mmol/L to 0.32%. However, in comparison to other published protocols it is still a very low level of hypoglycaemia and less than clinically acceptable value of 5% <4.0mmol/L. More importantly this study shows great promise for the future of CGM and their use in clinic. With the a newer generation of sensors, specifically designed for the ICU, promising less noise and drift suggesting that a reduced nurse workload without compromising safety or performance is with in reach. 
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